Unichem gets USFDA nod for Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg

Unichem Laboratories is pleased to announce that it has received ANDA approval for its Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Cardura (Doxazosin) Tablets, 1 mg, 2 mg, 4 mg and 8 mg, of Viatris Specialty, LLC.

Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure. The product will be commercialised from Unichem’s Goa Plant.